The in vitro activity of the semisynthetic glycopeptide amide MDL 63,246 against 293 U.S. clinical isolates of gram-positive cocci was determined by the broth microdilution method. When compared with teicoplanin, MDL 63,246 had improved activity against Staphylococcus epidermidis (MICs that inhibited 90% strains tested [MIC90s], 0.25 versus 8 micrograms/ml, respectively). Staphylococcus haemolyticus (MIC90s, 1 versus 32 micrograms/ml, respectively), and VanA Enterococcus faecium (MIC90s, 32 versus > or = 1,024 micrograms/ml, respectively).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC162786 | PMC |
| http://dx.doi.org/10.1128/AAC.39.7.1589 | DOI Listing |
Publication Analysis
Top Keywords
mdl 63246
12
vitro activity
8
activity semisynthetic
8
semisynthetic glycopeptide
8
glycopeptide amide
8
amide mdl
8
versus micrograms/ml
8
mic90s versus
8
63246 vitro
4
63246 293
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!